Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anvarsadat Kianmehr
Production of a Germline-Humanized Cetuximab scFv and Evaluation of Its Activity in Recognizing EGFR- Overexpressing Cancer Cells
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
Chaperone-Assisted Soluble Expression of a Humanized Anti-Egfr ScFv Antibody in E. Coli
Advanced Pharmaceutical Bulletin
Toxicology
Pharmaceutics
Pharmacology
Pharmaceutical Science
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt
Journal of Cancer
Oncology
Sulforaphane-Conjugated Carbon Dots: A Versatile Nanosystem for Targeted Imaging and Inhibition of EGFR-Overexpressing Cancer Cells
Association of EGFR Expression Level and Cetuximab Activity in Patient-Derived Xenograft Models of Human Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Simulation-Based Engineering of Humanized SCFV Antibody Against hTNF-α
Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
Targeting Nuclear EGFR: Strategies for Improving Cetuximab Therapy in Lung Cancer
Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations
Cancer Discovery
Oncology
Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-Egfr Affibody
Frontiers in Pharmacology
Pharmacology